{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T13:51:21Z","timestamp":1782654681690,"version":"3.54.5"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI 18\/01016"],"award-info":[{"award-number":["PI 18\/01016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) is a ligand-activated nuclear receptor that regulates glucose and lipid metabolism. Pharmacological activators of PPAR\u03b3 are being used as a treatment of obesity related disorders such as dyslipidaemia and type 2 diabetes, but questions remain open regarding the effects of PPAR\u03b3 on traits related to the development of type 2 diabetes. In our study, we have analyzed the relationship of the common variant Pro12Ala in the human PPAR\u03b32 gene with the presence of obesity and with insulin, HOMA and lipid profile in a representative sample of 6-to 8-year-old children free from the confounding factors associated with adults. We found that Ala12Ala genotype was significantly more frequent in females with obesity than in those without obesity, with Ala12Ala carriers having significantly higher weight and body mass index (BMI), however the association disappeared when adjusting by leptin concentrations. The Ala12Ala genotype was associated with significantly higher HDL-cholesterol and apoA-I levels in males but not in females, independently of BMI. In a recessive model, in females, leptin levels appeared higher in Ala12Ala carriers. Although no apparent differences were observed in any sex when analyzing insulin levels and HOMA among genotypes without adjusting, lower insulin levels and lower HOMA appeared associated with Ala12Ala carriers when adjusting for BMI and leptin levels. In summary, our data showed that leptin seems to be having an effect on the association between the PPAR\u03b32 Pro12Ala and BMI. Besides, after controlling for BMI and leptin, a protective effect of the Ala12Ala variant of the PPAR\u03b32 Pro12Ala polymorphism on insulin sensitivity is evident already in prepubertal children.<\/jats:p>","DOI":"10.3389\/fphar.2021.763853","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:38:55Z","timestamp":1638275935000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["PPAR\u03b32 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes"],"prefix":"10.3389","volume":"12","author":[{"given":"Claudia","family":"Vales-Villamar\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaya","family":"de Dios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"P\u00e9rez-Nadador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gavela-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Soriano-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/79216","article-title":"The Common PPARgamma Pro12Ala Polymorphism Is Associated with Decreased Risk of Type 2 Diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.2337\/diabetes.47.11.1806","article-title":"Association of the Pro12Ala Variant in the Peroxisome Proliferator-Activated Receptor-Gamma2 Gene with Obesity in Two Caucasian Populations","volume":"47","author":"Beamer","year":"1998","journal-title":"Diabetes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1515\/bjmg-2017-0007","article-title":"Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor \u03b32 Gene on Lipid Profile and Adipokines Levels in Obese Subjects","volume":"20","author":"Becer","year":"2017","journal-title":"Balk. J. Med. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/iub.1596","article-title":"Obesity-Related Genetic Polymorphisms and Adiposity Indices in a Young Italian Population","volume":"69","author":"Bordoni","year":"2017","journal-title":"IUBMB Life"},{"key":"B5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1203\/01.PDR.0000147728.62185.21","article-title":"PPAR-gamma2 Pro12Ala Variant Is Associated with Greater Insulin Sensitivity in Childhood Obesity","volume":"57","author":"Buzzetti","year":"2005","journal-title":"Pediatr. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11010-005-1353-8","article-title":"Leptin Down-Regulates Peroxisome Proliferator-Activated Receptor Gamma (PPAR-Gamma) mRNA Levels in Primary Human Monocyte-Derived Macrophages","volume":"275","author":"Cabrero","year":"2005","journal-title":"Mol. Cel. Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","article-title":"Thiazolidinediones and PPAR\u03b3 Agonists: Time for a Reassessment","volume":"23","author":"Cariou","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11892-021-01385-5","article-title":"PPAR\u03b3 and Diabetes: Beyond the Genome and towards Personalized Medicine","volume":"21","author":"Cataldi","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s00125-005-1817-0","article-title":"The Pro12Ala and C-681G Variants of the PPARG Locus Are Associated with Opposing Growth Phenotypes in Young Schoolchildren","volume":"48","author":"Cecil","year":"2005","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/jpem-2018-0288","article-title":"No Clinical Utility of Common Polymorphisms in IGF1, IRS1, GCKR, PPARG, GCK1 and KCTD1 Genes Previously Associated with Insulin Resistance in Overweight Children from Romania and Moldova","volume":"32","author":"Chirita-Emandi","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/sj.ijo.0801210","article-title":"The Pro12Ala Variant of Peroxisome Proliferator-Activated Receptor-Gamma2 (PPAR-Gamma2) Is Associated with Measures of Obesity in Mexican Americans","volume":"24","author":"Cole","year":"","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a Standard Definition for Child Overweight and Obesity Worldwide: International Survey","volume":"320","author":"Cole","year":"","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.orcp.2014.06.001","article-title":"Effects of Energy Expenditure Gene Polymorphisms on Obesity-Related Traits in Obese Children","volume":"9","author":"Csernus","year":"2015","journal-title":"Obes. Res. Clin. Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/EJE-09-0631","article-title":"The PPAR-Gamma Pro12Ala Polymorphism Associates with Weight Gain during GH-Treatment in Short Children Born Small for Gestational Age","volume":"162","author":"De Kort","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1172\/JCI118860","article-title":"Thiazolidinediones Repress Ob Gene Expression in Rodents via Activation of Peroxisome Proliferator-Activated Receptor Gamma","volume":"98","author":"De Vos","year":"1996","journal-title":"J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1515\/CCLM.2009.242","article-title":"Peroxisome Proliferator-Activated Receptor-Gamma (PPARgamma) Pro12Ala Polymorphism and Risk for Pediatric Obesity","volume":"47","author":"Dedoussis","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala Substitution in PPARgamma2 Associated with Decreased Receptor Activity, Lower Body Mass index and Improved Insulin Sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2337\/diabetes.50.4.886","article-title":"The Peroxisome Proliferator-Activated Receptor-Gamma2 Pro12A1a Variant: Association with Type 2 Diabetes and Trait Differences","volume":"50","author":"Douglas","year":"2001","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.dsx.2014.07.002","article-title":"Studying Progression from Glucose Intolerance to Type 2 Diabetes in Obese Children","volume":"8","author":"Dubinina","year":"2014","journal-title":"Diabetes Metab. Syndr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s001250100629","article-title":"Studies of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor-Gamma2 (PPAR-Gamma2) Gene in Relation to Insulin Sensitivity Among Glucose Tolerant Caucasians","volume":"44","author":"Ek","year":"2001","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1210\/jc.2006-2275","article-title":"Effects of the Type 2 Diabetes-Associated PPARG P12A Polymorphism on Progression to Diabetes and Response to Troglitazone","volume":"92","author":"Florez","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/oby.2005.111","article-title":"Obesity in Spanish Schoolchildren: Relationship with Lipid Profile and Insulin Resistance","volume":"13","author":"Garc\u00e9s","year":"2005","journal-title":"Obes. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2350-6-11","article-title":"Implication of the Pro12Ala Polymorphism of the PPAR-Gamma 2 Gene in Type 2 Diabetes and Obesity in the French Population","volume":"6","author":"Ghoussaini","year":"2005","journal-title":"BMC Med. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/eje.0.1470495","article-title":"Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene on Adiposity, Insulin Sensitivity and Lipid Profile in the Spanish Population","volume":"147","author":"Gonz\u00e1lez S\u00e1nchez","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/aje\/kwp450","article-title":"The Association between the Peroxisome Proliferator-Activated Receptor-Gamma2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: a HuGE Review and Meta-Analysis","volume":"171","author":"Gouda","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1006\/bbrc.2000.2605","article-title":"The Pro12Ala Polymorphism in PPAR Gamma2 May Confer Resistance to Type 2 Diabetes","volume":"271","author":"Hara","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1017\/S0007114507665179","article-title":"The Minor Allele of the PPARgamma2 pro12Ala Polymorphism Is Associated with Lower Postprandial TAG and Insulin Levels in Non-obese Healthy Men","volume":"97","author":"Helwig","year":"2007","journal-title":"Br. J. Nutr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/JPEM.2011.111","article-title":"PPAR-Gamma2 pro12Ala Polymorphism Is Associated with Post-Challenge Abnormalities of Glucose Homeostasis in Children and Adolescents with Obesity","volume":"24","author":"Jermendy","year":"2011","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/17477160802263194","article-title":"Interaction Between PPARG Pro12Ala and ADIPOQ G276T Concerning Cholesterol Levels in Childhood Obesity","volume":"4","author":"Johansson","year":"2009","journal-title":"Int. J. Pediatr. Obes."},{"key":"B31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/1871530319666190228102212","article-title":"The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects","volume":"19","author":"Khatami","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"B32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1358\/dnp.2002.15.6.701652","article-title":"The Role of PPARgamma Ligands as Regulators of the Immune Response","volume":"15","author":"Kwak","year":"2002","journal-title":"Drug News Perspect."},{"key":"B33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1573399814666180912130401","article-title":"Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-Analysis","volume":"15","author":"Li","year":"2019","journal-title":"Curr. Diabetes Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2337\/diabetes.52.5.1265","article-title":"The Peroxisome Proliferator-Activated Receptor-Gamma2 Gene Polymorphism (Pro12Ala) Beneficially Influences Insulin Resistance and its Tracking from Childhood to Adulthood: the Bogalusa Heart Study","volume":"52","author":"Li","year":"2003","journal-title":"Diabetes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.2337\/diabetes.48.7.1466","article-title":"Pro12Ala Substitution in the Peroxisome Proliferator-Activated Receptor-Gamma2 Is Not Associated with Type 2 Diabetes","volume":"48","author":"Mancini","year":"1999","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1469-1809.2011.00668.x","article-title":"A Replication Study of the IRS1, CAPN10, TCF7L2, and PPARG Gene Polymorphisms Associated with Type 2 Diabetes in Two Different Populations of Mexico","volume":"75","author":"Mart\u00ednez-G\u00f3mez","year":"2011","journal-title":"Ann. Hum. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/jmg.40.10.773","article-title":"Effect of the Peroxisome Proliferator Activated Receptor-Gamma Gene Pro12Ala Variant on Body Mass index: A Meta-Analysis","volume":"40","author":"Masud","year":"2003","journal-title":"J. Med. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.ijo.0801112","article-title":"Impact of the Peroxisome Proliferator Activated Receptor Gamma2 Pro12Ala Polymorphism on Adiposity, Lipids and Non-Insulin-Dependent Diabetes Mellitus","volume":"24","author":"Meirhaeghe","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/bbrc.1998.9421","article-title":"Effect of the Pro12Ala Variant of the Human Peroxisome Proliferator-Activated Receptor Gamma 2 Gene on Adiposity, Fat Distribution, and Insulin Sensitivity in Japanese Men","volume":"251","author":"Mori","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1590\/1678-4685-GMB-2015-0267","article-title":"Polymorphisms FTO Rs9939609, PPARG Rs1801282 and ADIPOQ Rs4632532 and Rs182052 but Not Lifestyle Are Associated with Obesity Related-Traits in Mexican Children","volume":"39","author":"Mu\u00f1oz-Y\u00e1\u00f1ez","year":"2016","journal-title":"Genet. Mol. Biol."},{"key":"B42","first-page":"1801","article-title":"Significance of Pro12Ala Mutation in Peroxisome Proliferator-Activated Receptor-Gamma2 in Korean Diabetic and Obese Subjects","volume-title":"J. Clin. Endocrinol. Metab.","author":"Oh","year":"2000"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2337\/diacare.2951046","article-title":"Role of Genetic Polymorphism Peroxisome Proliferator-Activated Receptor-Gamma2 Pro12Ala on Ethnic Susceptibility to Diabetes in South-Asian and Caucasian Subjects: Evidence for Heterogeneity","volume":"29","author":"Radha","year":"2006","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1006\/bbrc.1998.9962","article-title":"Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor Gamma and Diabetes Mellitus","volume":"254","author":"Ringel","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/dmrr.371","article-title":"The Pro12Ala PPARgamma2 Gene Missense Mutation Is Associated with Obesity and Insulin Resistance in Swedish Middle-Aged Men","volume":"19","author":"Rosmond","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1203\/01.pdr.0000238259.41560.00","article-title":"PPAR-gamma2 Pro12Ala Variant, Insulin Resistance and Plasma Long-Chain Polyunsaturated Fatty Acids in Childhood Obesity","volume":"60","author":"Scaglioni","year":"2006","journal-title":"Pediatr. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000064490","article-title":"Pro12Ala Substitution in the Peroxisome Proliferator-Activated Receptor-Gamma Is Associated with Increased Leptin Levels in Women with Type-2 Diabetes Mellitus","volume":"58","author":"Sim\u00f3n","year":"2002","journal-title":"Horm. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: Adipogenic Regulator and Thiazolidinedione Receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"24472","DOI":"10.1038\/srep24472","article-title":"Association between PPAR-\u03932 Pro12Ala Genotype and Insulin Resistance Is Modified by Circulating Lipids in Mexican Children","volume":"6","author":"Stryjecki","year":"2016","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"876","DOI":"10.2337\/diabetes.50.4.876","article-title":"Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-Gamma2 Gene Is Associated with Increased Antilipolytic Insulin Sensitivity","volume":"50","author":"Stumvoll","year":"2001","journal-title":"Diabetes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.2337\/dc06-0513","article-title":"Association of Pro12Ala Polymorphism in Peroxisome Proliferator-Activated Receptor Gamma with Pre-diabetic Phenotypes: Meta-Analysis of 57 Studies on Nondiabetic Individuals","volume":"29","author":"T\u00f6njes","year":"2006","journal-title":"Diabetes Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor \u03b3 (hPPAR\u03b3) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPAR\u03b32 Missense Mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"9455","DOI":"10.1074\/jbc.271.16.9455","article-title":"Down-Regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and Db\/db Mice","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1194\/jlr.M004481","article-title":"Pioglitazone Increases Apolipoprotein A-I Production by Directly Enhancing PPRE-Dependent Transcription in HepG2 Cells","volume":"51","author":"Zhang","year":"2010","journal-title":"J. Lipid Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.763853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:38:58Z","timestamp":1638275938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.763853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":55,"alternative-id":["10.3389\/fphar.2021.763853"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.763853","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"article-number":"763853"}}